Individualized Treatment Effect Inference of Head and Neck Cancer with Multimodal Data
Yawen Wei1,2, Zhen Li1, Jonghye Woo3
1Department of Radiology and Biomedical Imaging, Yale School of Medicine, Yale University, New Haven, CT.
None:
Estimating individualized treatment effects (ITE) is critical for personalized medicine, yet it remains a challenge due to retrospective observational data, which suffer from selection bias in clinical practice, and the complexity of multimodal data used for patient status depiction. In this work, we develop an end-to-end deep learning (DL) framework that incorporates multimodal patient data and multiple treatments for accurate ITE inference in a retrospective head and neck cancer (HNC) study. A possible solution is concatenating the factors and adapt adversarial training, which has shown great promise on tabular data, to disentangle patient characteristics from patient status features to mitigate treatment selection bias. However, this approach suffers from instability when applied to complex multimodal patient data and multiple treatment options. For flexible and efficient, treatment-conditioned information fusion, we propose a bi-stage adaptive instance normalization (Bi-AdaIN) to inject relevant factors into corresponding layers, an approach that is also robust to missing values. Furthermore, we propose to disentangle status features from the multi-treatment variable using mutual information (MI) regularization, enabling more accurate predictions of patient-specific outcomes for both factual and counterfactual data. We evaluated our model on the RADCURE dataset, comprising 3,346 HNC cases with CT scans and multiple clinical variables who received radiotherapy or additional chemotherapy and EGFRI. The Bias-Adjusted Treatment Effect (BATE) is substantially reduced compared to the conventional direct ITE method (which does not consider treatment bias) and to adversarial training, indicating a more robust estimation of causal effects. This work is one of the first DL-based studies to address ITE estimation using multimodal medical imaging, offering a promising approach to counterfactual reasoning in clinical oncology for decision support.
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
